Sir John Iredale (born 1960) [1] is a British academic and medical doctor. He is Pro Vice Chancellor for Health, and Chair of Experimental Medicine, at the University of Bristol. He specialises in pancreatic and hepatobiliary medicine. [2]
Iredale was born in Oxford on 9 November 1960. [1] His father was the director of the Harwell laboratory of the UK Atomic Energy Authority in Oxfordshire. [3] He attended the City of Oxford High School for Boys. In 1985, Iredale graduated with a Bachelor of Medicine with Honours from the University of Southampton. [1]
Between 1991 and 2003, Iredale held a number of externally funded Medical Research Council Fellowships; he held a Training Fellowship, then a Clinician Scientist Fellowship, and then a Senior Clinical Fellowship. [4] Iredale received a Doctor of Medicine from the University of Southampton in 1995 [1] . He carried out most or all of the work for the MRC Fellowships at the University of Southampton, and from 1998 until 2004 he was Professor of Hepatology at the University. [5]
Between 2004 and 2006, Iredale was Professor of Medicine at the University of Southampton. [5] In 2006, Iredale became a Consultant Hepatologist at Edinburgh Royal Infirmary, a role he remained in until 2016. [1] Also in 2006, he became Chair of Medicine at the University of Edinburgh, a role he served in until 2013. [6] Iredale left the University of Edinburgh in 2016. [7] While at the University of Edinburgh, Iredale served as Vice Principal Health Services and Dean of Clinical Medicine. [6] As of 2008, he was part of the MRC Centre for Regenerative Medicine at the University. [8] Iredale also served as a Non-Executive Director of NHS Lothian between 2010 and 2016. [9]
Iredale joined the University of Bristol in 2016. [10] As of December 2021, Iredale was an Honorary Consultant and Non-Executive Director at North Bristol NHS Trust. [11] In January 2022, Iredale became Interim Executive Chair of the UK Medical Research Council, although he had been a member of the Council from 2016; [12] he stepped down from his position as Pro Vice-Chancellor for Health and Life Sciences at the University of Bristol in order to carry out this interim role. [11] In September 2022, Iredale became the Chair of the Lister Institute of Preventative Medicine, [13] having previously been the Chair of the Scientific Advisory Committee of the Institute. [14] In November 2023, Iredale chaired a roundtable by the UK Government Office for Science about human genome databses. [15] As of December 2023, he was the Chair of the Cancer Research UK Scotland Institute's Board. [16] Iredale is now Pro Vice Chancellor Health at the University of Bristol. He also holds two Honorary Consultant contracts at NHS trusts. [9]
Iredale's honours include a Fellowship of the Royal College of Physicians of London (starting in 1999) [9] , a Fellowship of the Academy of Medical Sciences (starting in 2003) [2] and a knighthood (starting in 2024). [17]